T-cell regulation: with complements from innate immunity (original) (raw)

• Medhzitov, R. & Janeway, C. A. Jr. Decoding the patterns of self and non-self by the innate immune system. Science 296, 298–300 (2002).
  Article Google Scholar
• Walport, M. J. Complement. First of two parts. N. Engl. J. Med. 344, 1058–1066 (2001).
  Article CAS PubMed Google Scholar
• Walport, M. J. Complement. Second of two parts. N. Engl. J. Med. 344, 1140–1144 (2001).
  Article CAS PubMed Google Scholar
• Metschnikoff, E. Sur la lutte des cellule de l'organisme contre l'invasion des microbes. Ann. Inst. Pasteur 1, 321 (1887) (in French).
  Google Scholar
• Bordet, J. & Gengou, O. Sur l'existence de substances sensibilisatrices dans la plupart des serum antimicrobien. Ann. Inst. Pasteur 15, 289–302 (1901) (in French).
  Google Scholar
• Volanakis, J. E. in The Human Complement System in Health and Disease 10th edn (eds Volanakis, J. E. & Frank, M. M.) 9–32 (Marcel Dekker, New York, 1998).
  Book Google Scholar
• Morgan, B. P. & Harris, C. L. Complement Regulatory Proteins (Academic, New York, 1999).
  Google Scholar
• Kim, D. D. & Song, W.-C. Membrane complement regulatory proteins. Clin. Immunol. 118, 127–136 (2006).
  Article CAS PubMed Google Scholar
• Korb, L. C. & Ahearn, J. M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525–4528 (1997).
  CAS PubMed Google Scholar
• Botto M. et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19, 56–59 (1998).
  Article CAS PubMed Google Scholar
• Riley-Vargas, R. C., Lanzendorf, S. & Atkinson, J. P. Targeted and restricted complement activation on acrosome-reacted spermatozoa. J. Clin. Invest. 115, 1241–1249 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Harris, C. L., Mizuno, M. & Morgan, B. P. Complement and complement regulators in the male reproductive system. Mol. Immunol. 43, 57–67 (2006).
  Article CAS PubMed Google Scholar
• Nussenzweig, V., Bianco, C., Dukor, P. & Eden, A. in Progress in Immunology Vol. 59 (ed. Amos, B.) 73–81 (Academic, New York, 1971).
  Book Google Scholar
• Carroll, M. C. The complement system in regulation of adaptive immunity. Nature Immunol. 10, 981–986 (2004).
  Article CAS Google Scholar
• Mastellos, D. & Lambris, J. D. Complement: more than a 'guard' against invading pathogens? Trends Immunol. 23, 485–491 (2002).
  Article CAS PubMed Google Scholar
• Nielsen, C. H., Fischer, E. M. & Leslie, R. G. The role of complement in the acquired immune response. Immunology 100, 4–12 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Pepys, M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140, 126–145 (1974).
  Article CAS PubMed PubMed Central Google Scholar
• Carter, R. H., Spycher, M. O., Ng, Y. C., Hoffman, R. & Fearon, D. T. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141, 457–467 (1988).
  CAS PubMed Google Scholar
• Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C. & Fearon, D. T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348–350 (1996).
  Article CAS PubMed Google Scholar
• Fearon, D. T. & Carter, R. H. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Ann. Rev. Immunol. 13, 127–149 (1995).
  Article CAS Google Scholar
• Fang, Y., Xu, C., Fu, Y., Holer, V. M. & Molina, H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160, 5273–5279 (1998).
  CAS PubMed Google Scholar
• Molina, H. et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl Acad. Sci. USA 93, 3357–3361 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Carroll, M. C. The complement system in B cell regulation. Mol. Immunol. 41, 141–146 (2004).
  Article CAS PubMed Google Scholar
• Kemper, C. et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388–392 (2003). Provides evidence that a complement inhibitor influences T-cell responses through the generation of IL-10-producing regulatory T cells.
  Article CAS PubMed Google Scholar
• Morgan, B. P., Marchbank, K. J., Longhi M. P., Harris, C. L. & Gallimore, A. M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 97, 171–179 (2005).
  Article CAS PubMed Google Scholar
• Longhi, M. P., Harris, C. L., Morgan, B. P. & Gallimore, A. Holding T cell in check — a new role for complement regulators? Trends Immunol. 27, 102–108 (2006).
  Article CAS PubMed Google Scholar
• Hawlisch, H. & Köhl, J. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol. Immunol. 43, 13–21 (2006).
  Article CAS PubMed Google Scholar
• Köhl, J. et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116, 783–96 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Castellano, G. et al. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 103, 3813–3820 (2004).
  Article CAS PubMed Google Scholar
• Jiang, K., Chen, Y., Xu, C. S. & Jarvis, J. N. T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenisis of rheumatoid arthritis. Clin. Exp. Immunol. 131, 61–67 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Jacquier-Sarlin, M. R., Gabert, F. M., Villiers, M. B. & Colomb, M. G. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 84, 164–170 (1995).
  CAS PubMed PubMed Central Google Scholar
• Kerekes, K. et al. Adjuvant effect of γ-inulin is mediated by C3 fragments deposited on antigen-presenting cells. J. Leuk. Biol. 69, 69–74 (2001).
  CAS Google Scholar
• Marth, T. & Kelsall, B. L. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185, 1987–1995 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Hawlisch, H., Wills-Karp, M., Karp, C. L. & Köhl, J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 41, 123–131 (2004).
  Article CAS PubMed Google Scholar
• Sozzani, S. et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155, 3292–3295 (1995).
  CAS PubMed Google Scholar
• Wetsel, R. A. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7, 48–53 (1995).
  Article CAS PubMed Google Scholar
• Drouin, S. M., Corry, D. B., Kildsgaard, J. & Wetsel, R. A. Cutting edge: the absence of C3 demonstrates a role for complement in TH2 effector functions in a murine model of pulmonary allergy. J. Immunol. 167, 4141–4145 (2001). This report, along with references 38–41 and 56, delineates the impact of the anaphylatoxins on T-cell lineage commitment during APC–T-cell interactions.
  Article CAS PubMed Google Scholar
• Drouin, S. M., Corry, D. B., Hollman, T. J., Kildsgaard, J. & Wetsel, R. A. Absence of the complement anaphylatoxin C3a receptor suppresses TH2 functions in a murine model of pulmonary allergy. J. Immunol. 169, 5926–5933 (2002).
  Article CAS PubMed Google Scholar
• Gerard, N. P. & Gerard, C. Complement in allergy and asthma. Curr. Opin. Immunol. 14, 705–708 (2002).
  Article CAS PubMed Google Scholar
• Kawamoto, S. et al. The anaphylatoxin C3a downregulates the TH2 response to epicutaneously introduced antigen. J. Clin. Invest. 114, 399–407 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hawlisch, H. et al. C5a negatively regulates Toll-like receptor 4-induced immune responses. Immunity 22, 415–426 (2005).
  Article CAS PubMed Google Scholar
• Källström, H., Islam, M. S., Berggren, P. O. & Jonsson, A. B. Cell signaling by the type IV pili of pathogenic Neisseria. J. Biol. Chem. 273, 21777–21782 (1998).
  Article PubMed Google Scholar
• Karp, C. L. et al. Mechanisms of suppression of cell-mediated immunity by measles virus. Science 273, 228–231 (1996). Measles virus uses the immunomodulatory properties of a complement regulator to suppress the immune response.
  Article CAS PubMed Google Scholar
• Cattaneo, R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 78, 4385–4388 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Heeger, P. S. et al. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201, 1523–1530 (2005). Shows that complement components produced by APCs on antigen encounter modulate subsequent cytokine production by T cells.
  Article CAS PubMed PubMed Central Google Scholar
• Helmy, K. Y. et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915–927 (2006).
  Article CAS PubMed Google Scholar
• Kang, Y.-S. et al. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 125, 47–58 (2006).
  Article CAS PubMed Google Scholar
• Wagner, C. & Hänsch, G. M. Receptors for complement C3 on T-lymphocytes: relics of evolution or functional molecules. Mol. Immunol. 43, 22–30 (2006).
  Article CAS PubMed Google Scholar
• Wilson, J. G., Tedder, T. F. & Fearon, D. T. Characterization of human T cells that express the C3b receptor. J. Immunol. 131, 684–689 (1983).
  CAS PubMed Google Scholar
• Wagner, C. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol. Immunol. 43, 643–651 (2006).
  Article CAS PubMed Google Scholar
• Muto, S., Vetvicka, V. & Ross, G. D. CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J. Clin. Immunol. 13, 175–184 (1993).
  Article CAS PubMed Google Scholar
• Eggleton, P., Tenner, A. J. & Reid, K. B. M. C1q receptors. Clin. Exp. Immunol. 120, 406–412 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, A. et al. Human T cells express specific sites for C1q: role in T cell activation and proliferation. J. Immunol. 153, 1430–1440 (1994).
  CAS PubMed Google Scholar
• Nataf, S., Davoust, N., Ames, R. S. & Barnum, S. A. Human T cells express the C5a receptor and are chemoattracted to C5a. J. Immunol. 162, 4018–4023 (1999).
  CAS PubMed Google Scholar
• Tsuji, R. F. et al. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165, 1588–1598 (2000).
  Article CAS PubMed Google Scholar
• Grant, E. P. et al. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J. Exp. Med. 196, 1461–1471 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Werfel, T. et al. Activated human T lymphocytes express a functional C3a receptor. J. Immunol. 165, 6599–6605 (2000).
  Article CAS PubMed Google Scholar
• Astier, A. L., Trescol-Biemont, M.-C., Azocar, O., Lamouille, B. & Rabourdin-Combe, C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 164, 6091–6095 (2000). Establishes that signalling through CD46 modulates T-cell proliferation. This paper laid the ground work for the subsequent studies of the effects on T-cell function induced by CD46 crosslinking.
  Article CAS PubMed Google Scholar
• Grossman, W. J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589–601 (2004). Establishes a simple paradigm for how regulatory T cells might influence immune responses. In humans, natural T Reg cells synthesize granzyme A, whereas adaptive regulatory T cells produce granzyme B. On CD46 activation both cell types can kill activated, immunocompetent cells.
  Article CAS PubMed Google Scholar
• Sanchez, A., Feito, M. J. & Rojo, J. M. CD46-mediated costimulation induces a TH1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur. J. Immunol. 34, 2439–2448 (2004).
  Article CAS PubMed Google Scholar
• Liu, J. et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201, 567–577 (2005). This report, together with reference 45, shows that complement deposition on APCs and T cells influences T-cell proliferation and cytokine production during APC–T-cell interactions.
  Article CAS PubMed PubMed Central Google Scholar
• Korty, P. E., Brando, C. & Shevach, E. M. CD59 functions as a signal-transducing molecule for human T cell activation. J. Immunol. 146, 4092–4098 (1991).
  CAS PubMed Google Scholar
• Kopf, M., Abel, B., Gallimore, A., Carroll, M. & Bachmann, M. F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nature Med. 8, 373–378 (2002). References 63–68 indicate that complement activation (and natural antibodies) are required for optimal CD4+ and CD8+ T-cell responses to viral infections.
  Article CAS PubMed Google Scholar
• Suresh, M. et al. Complement component 3 is required for optimal expansion of CD8 T cells during a system viral infection. J. Immunol. 170, 788–794 (2003).
  Article CAS PubMed Google Scholar
• Verschoor, A., Brockman, M. A., Gadjeva, M., Knipe, D. M. & Carroll, M. C. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 171, 5363–5371 (2003).
  Article CAS PubMed Google Scholar
• Stager, S. et al. Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T cell responses. Nature Med. 9, 1287–1292 (2003).
  Article PubMed CAS Google Scholar
• Hopken, U. E., Lu, B., Gerard, N. P. & Gerard, C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383, 86–89 (1996).
  Article CAS PubMed Google Scholar
• Kim, A. H. et al. Complement C5a receptor is essential for the optimal generation of CD8+ T cell responses. J. Immunol. 173, 2524–2529 (2004).
  Article CAS PubMed Google Scholar
• Karp, C. L. et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nature Immunol. 1, 221–226 (2000).
  Article CAS Google Scholar
• Wittman, M. et al. C5a suppresses the production of IL-12 by IFN-γ-primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162, 6763–6769 (1999).
  Google Scholar
• Marie, J. C. et al. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nature Immunol. 3, 659–666 (2002). This in vivo study supports a role for CD46 in the regulation of T-cell responses. The authors used mice transgenic for human CD46 to modulate T-cell responses in a contact-hypersensitivity model.
  Article CAS Google Scholar
• Longhi, M. P., Sivasankar, B., Omidvar, N., Morgan, B. P. & Gallimore, A. Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner. J. Immunol. 175, 7098–7102 (2005).
  Article CAS PubMed Google Scholar
• Riley-Vargas, R. C., Gill, D. B., Kemper, C., Liszewski, M. K. & Atkinson, J. P. CD46: expanding beyond complement regulation. Trends Immunol. 25, 496–503 (2004).
  Article CAS PubMed Google Scholar
• Kemper, C., Verbsky, J. W., Price, J. D. & Atkinson, J. P. T cell stimulation and regulation: with complements from CD46. Immunol. Res. 32, 31–43 (2005).
  Article CAS PubMed Google Scholar
• Foley, S., Li, B., Dehoff, M., Molina, M. & Holers, V. M. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Euro. J. Immunol. 23, 1381–1384 (1993).
  Article CAS Google Scholar
• Fernandez-Centeno, E., de Ojeda, G., Rojo, J. M. & Portoles, P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J. Immunol. 164, 4533–4542 (2000).
  Article CAS PubMed Google Scholar
• Elward, et al. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280, 36342–36354 (2005). Shows that the expression profile of complement receptors and regulators can send inhibitory (or inducing) phagocytic signals. Proposes, together with reference 79, new roles for complement in the apoptotic process in addition to its function in the safe removal of dead cells.
  Article CAS PubMed Google Scholar
• Cole, D. S., Hughes, T. R., Gasque, P. & Morgan, B. P. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol. Immunol. 43, 1953–1964 (2006).
  Article CAS PubMed Google Scholar
• Legembre, P. et al. Cutting edge: modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytes. J. Immunol. 176, 716–720 (2006).
  Article CAS PubMed Google Scholar
• Grossmann, W. et al. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104, 2840–2848 (2004).
  Article CAS Google Scholar
• Bluestone, J. A. & Abbas, A. K. Natural versus adapative regulatory T cells. Nature Rev. Immunol. 3, 253–257 (2003).
  Article CAS Google Scholar
• Jonuleit, H. & Schmitt, E. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171, 6323–6327 (2003).
  Article CAS PubMed Google Scholar
• Price, J. D. et al. Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J. Immunol. 175, 677–684 (2005).
  Article CAS PubMed Google Scholar
• Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997).
  Article CAS PubMed Google Scholar
• Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995–1004 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S. & Noelle, R. J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783–1786 (2005).
  Article CAS PubMed Google Scholar
• Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunol. 6, 345–352 (2005).
  Article CAS Google Scholar
• Fukaura, H. et al. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting TH3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98, 70–77 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• O'Garra, A. & Vieira, P. Regulatory T cells and mechanisms of immune system control. Nature Med. 10, 801–805 (2004).
  Article CAS PubMed Google Scholar
• Barchet, W. et al. Complement-induced regulatory T cells suppress T cell responses but allow for dendritic cell activation. Blood 107, 1497–1504 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Cong, Y., Weaver, C. T., Lazenby, A. & Elson, C. O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to enteric flora. J. Immunol. 169, 6112–6119 (2002).
  Article CAS PubMed Google Scholar
• Kuhn, R., Lohler, J., Rennick, D., Rajewski, K. & Müller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263–274 (1993).
  Article CAS PubMed Google Scholar
• Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253–261 (1993).
  Article CAS PubMed Google Scholar
• McGuirk, P., McCann, C. & Mills, K. H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221–231 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lavelle, E. C. et al. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 171, 2384–2392 (2003).
  Article CAS PubMed Google Scholar
• Russel, S. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 64, 111–118 (2004).
  Article CAS Google Scholar
• Wang, G., Liszewski, M. K., Chan, A. C. & Atkinson, J. P. Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J. Immunol. 164, 1839–1846 (2000).
  Article CAS PubMed Google Scholar
• Kurita-Taniguchi, M. et al. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46. J. Immunol. 165, 5143–5152 (2000).
  Article CAS PubMed Google Scholar
• Ludford-Menting, M. J. et al. A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization. J. Biol. Chem. 277, 4477–4484 (2002).
  Article CAS PubMed Google Scholar
• Zaffran, Y. et al. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 167, 6780–6785 (2001).
  Article CAS PubMed Google Scholar
• Davis, L. S., Patel, S. S., Atkinson, J. P. & Lipsky, P. E. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J. Immunol. 141, 2246–2252 (1988).
  CAS PubMed Google Scholar
• Loertscher, R. & Lavery, P. The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation. Transpl. Immunol. 9, 93–96 (2002).
  Article CAS PubMed Google Scholar
• Pratt, J. R., Basher, S. A. & Sacks, S. H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nature Med. 8, 582–587 (2002). Complement mediates graft rejection through mechanisms that include increases in pro-inflammatory cytokine secretion by vessel walls and the recruitment of effector T cells.
  Article CAS PubMed Google Scholar
• Sacks, S. H., Chowdhury, P. & Zhou, W. Role of the complement system in rejection. Curr. Opin. Immunol. 15, 487–492 (2003).
  Article CAS PubMed Google Scholar
• Makrides, S. C. Therapeutic inhibition of the complement system. Pharm. Rev. 50, 59–87 (1998).
  CAS PubMed Google Scholar